26 February 2020

Radboudumc PhD-candidate Nina Wubben (Department of Intensive Care (IC)) has won the best abstract prize at the Dutch Intensive Care conference on February 7th for her research into predicting quality of life after an ICU-admission.
 
Annually over 85.000 patients are admitted to Dutch ICUs. Even though the number of ICU-survivors has been steadily increasing over the past decades, little is known about their long-term health. ICU survivors can suffer from prolonged physical, mental and cognitive health problems, and even for ICU survivors that do not experience these issues, (complete) recovery can take an unexpectedly long time.
To provide ICU doctors, ICU nurses, and patients and families with more insight in the long-term health outcomes of an ICU admission, a statistical model has been developed to predict quality of life one year after ICU admission. Because after all, it is not just about survival, but about surviving with a good quality of life.
To do this, data from the MONITOR-IC study was used (www.monitor-ic.nl): a prospective cohort study that collects a host of patient reported outcomes of thousands of adult ICU patients. Follow-up lasts up to five years after admission.
Under supervision of Dr Marieke Zegers, Dr Mark van den Boogaard and Professor Hans van der Hoeven, Nina Wubben, MSc developed a prediction model for change in quality of life one year after ICU-admission. Important predictors were, among others, quality of life and the level of frailty before admission. The small number of predictors make the model practically useable.
In the coming months, the use of the prediction model will be tested in existing conversations between ICU doctors and patients and their families. Here, the added value of using long-term health information in ICU practice will be assessed, as well as whether such information can help with speaking about life after an ICU admission.
This project is financed by the National Health Care Institute (ZIN).
 

Related news items


BRAINMODEL: precision medicine for brain disorders

25 October 2021

A team of researchers from Radboudumc, VU Amsterdam and other institutes is going to look for new and better ways to heal developmental disorders in the brain.

read more

How healthy is James Bond? - A flu to a kill No time to die: the pathogens surrounding secret agent 007

21 October 2021

James Bond made a total of 25 films between 1962 and 2021. In all those films, secret agent 007 washed his hands only twice, even though he often stayed in not so hygienic places with considerable health risks. Radboudumc researchers examined all the health risks in the 47 countries Bond visited.

read more

Surprisingly dominant cause underlying type I congenital defect of glycosylation

21 October 2021

Alex Garanto, Melissa Bärenfänger, Mirian Janssen, and Dirk Lefeber published a new study, identifying a surprisingly dominant genetic cause underlying type I congenital defect of glycosylation with neuromusculoskeletal phenotypes.

read more

Sensitive blood-test as a patient-friendly alternative for bone marrow-based cancer monitoring

20 October 2021

Hans Jacobs and Pieter Langerhorst, theme Cancer development and immune defense, and colleagues are one step closer to implementation of personalized diagnostics for bone marrow-based cancer monitoring.

read more

Register for peer coaching for RIMLS PhD candidates

20 October 2021

As a PhD candidate, you are in the lead of your own learning process, but you don’t need to do this alone. Register for the peer-coaching group ‘Stay in the lead – Together’ before 11 November 2021.

read more